PRESENTED BY NAME HERE Important Information

kittie-lecroy
Published  · 10 slides · 0 views
↓ Download
PRESENTED BY NAME HERE Important Information
1 / 1
PRESENTED BY NAME HERE Important Information - slide 1 of 10 PRESENTED BY NAME HERE Important Information - slide 2 of 10 PRESENTED BY NAME HERE Important Information - slide 3 of 10 PRESENTED BY NAME HERE Important Information - slide 4 of 10 PRESENTED BY NAME HERE Important Information - slide 5 of 10 PRESENTED BY NAME HERE Important Information - slide 6 of 10 PRESENTED BY NAME HERE Important Information - slide 7 of 10 PRESENTED BY NAME HERE Important Information - slide 8 of 10 PRESENTED BY NAME HERE Important Information - slide 9 of 10 PRESENTED BY NAME HERE Important Information - slide 10 of 10
Description
PRESENTED BY NAME HERE Important Information Regarding CME The CMEevaluation process will only be available on the USCAP website until September 30, 2027. No claims can be processed after that date! After September 30, 2027 you will NOT be

Related Topics

Download this presentation From Below

"PRESENTED BY NAME HERE Important Information" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Presentation Transcript

01
PRESENTED BY NAME HERE<br>
02
Important Information Regarding CME The CME/evaluation process will only be available on the USCAP website until September 30, 2027.

No claims can be processed after that date!

After September 30, 2027 you will NOT be able to obtain any CME credits for attending this meeting.<br>
03
Disclosure of Relevant Financial Relationships The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. USCAP has reviewed the disclosures and mitigated all relevant financial relationships.
The following faculty reported the following relevant financial relationships: NAME, COMPANY, RELEVANT RELATIONSHIPS (i.e. John Smith, Advisory Board Member, PharmaXYZ; Research Grant PharmaABC)

OR

The following faculty reported no relevant financial relationships: NAME HERE

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.<br>